Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if STRO is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
24 top institutions tracked
Last 13F trend: distributing (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 2
100 filers reported a long position in STRO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $43.3M | 1.3M | +82.4% |
| BVF INC/IL | $41.6M | 1.3M | Unchanged |
| Affinity Asset Advisors, LLC | $38.9M | 1.2M | +9.6% |
| BlackRock, Inc. | $37.3M | 1.1M | +382.5% |
| Samsara BioCapital, LLC | $35.3M | 1.1M | Unchanged |
| Kynam Capital Management, LP | $29M | 872.6K | Unchanged |
| ORBIMED ADVISORS LLC | $24.7M | 743.9K | -7.1% |
| BALYASNY ASSET MANAGEMENT L.P. | $23.6M | 711.2K | +52.7% |
| VANGUARD CAPITAL MANAGEMENT LLC | $23M | 694.2K | -3.6% |
| EVENTIDE ASSET MANAGEMENT, LLC | $19.4M | 585.3K | -18.2% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.